The University of Michigan has come up with a new urine test that can detect prostate cancer early

The British newspaper "Daily Mail" revealed that a new urine test could reveal an aggressive form of prostate cancer. The University of Michigan Rogel Cancer Center has developed a new test called the Prostate Urine Sequence Test (UPSeq) that analyzes 15 specific strands of DNA. Together, the mRNA looks for specific genes, which are "overexpressed" in cancer patients.

In clinical trials, the team found that the UPSeq blood test outperformed the PSA test, which measures the amount of PSA in the blood to detect cancer.

The UPSeq urine test, the researchers added, can be faster, cheaper, and easier to use, and can detect cancer early enough before the disease shows signs of worsening, and the test was developed by a team at the University of Michigan Rogel Cancer Center, and it is a test called the Urine Prostate Seq test. In short UPSeq.

It collects a urine sample from men after a digital rectal exam and uses genetic sequences to analyze the fluid, and researchers emphasized that it can detect cancer early enough before the disease shows signs of worsening.

According to the American Cancer Society, prostate cancer is the most common type of cancer among American men other than skin cancer, and it is estimated that one in 8 men will be diagnosed with prostate cancer during their lifetime.

Prostate cancer is usually diagnosed by first performing a digital rectal exam or blood test. The patient may undergo a transrectal ultrasound, magnetic resonance imaging or a prostate biopsy.